nodes	percent_of_prediction	percent_of_DWPC	metapath
Toremifene—CYP1A1—kidney cancer	0.274	0.653	CbGaD
Toremifene—ABCB1—kidney cancer	0.145	0.347	CbGaD
Toremifene—ABCB1—Temsirolimus—kidney cancer	0.0402	0.102	CbGbCtD
Toremifene—CYP1A1—Erlotinib—kidney cancer	0.0386	0.0979	CbGbCtD
Toremifene—CYP3A4—Everolimus—kidney cancer	0.0356	0.0905	CbGbCtD
Toremifene—CYP1A2—Pazopanib—kidney cancer	0.0241	0.0613	CbGbCtD
Toremifene—CYP3A4—Temsirolimus—kidney cancer	0.0241	0.0611	CbGbCtD
Toremifene—ABCB1—Pazopanib—kidney cancer	0.0211	0.0536	CbGbCtD
Toremifene—ABCB1—Dactinomycin—kidney cancer	0.0193	0.049	CbGbCtD
Toremifene—CYP1A2—Erlotinib—kidney cancer	0.0172	0.0437	CbGbCtD
Toremifene—ABCB1—Gemcitabine—kidney cancer	0.0153	0.0387	CbGbCtD
Toremifene—ABCB1—Erlotinib—kidney cancer	0.0151	0.0382	CbGbCtD
Toremifene—CYP1A2—Sorafenib—kidney cancer	0.014	0.0355	CbGbCtD
Toremifene—ABCB1—Paclitaxel—kidney cancer	0.0138	0.035	CbGbCtD
Toremifene—CYP3A4—Pazopanib—kidney cancer	0.0126	0.0321	CbGbCtD
Toremifene—ABCB1—Sorafenib—kidney cancer	0.0122	0.0311	CbGbCtD
Toremifene—ABCB1—Vinblastine—kidney cancer	0.0121	0.0307	CbGbCtD
Toremifene—ABCB1—Vincristine—kidney cancer	0.0119	0.0302	CbGbCtD
Toremifene—ABCB1—Sunitinib—kidney cancer	0.00992	0.0252	CbGbCtD
Toremifene—CYP3A4—Erlotinib—kidney cancer	0.00902	0.0229	CbGbCtD
Toremifene—CYP3A4—Paclitaxel—kidney cancer	0.00826	0.021	CbGbCtD
Toremifene—ABCB1—Doxorubicin—kidney cancer	0.00743	0.0189	CbGbCtD
Toremifene—CYP3A4—Sorafenib—kidney cancer	0.00734	0.0186	CbGbCtD
Toremifene—CYP3A4—Vinblastine—kidney cancer	0.00725	0.0184	CbGbCtD
Toremifene—CYP3A4—Vincristine—kidney cancer	0.00712	0.0181	CbGbCtD
Toremifene—CYP3A4—Sunitinib—kidney cancer	0.00594	0.0151	CbGbCtD
Toremifene—CYP3A4—Doxorubicin—kidney cancer	0.00445	0.0113	CbGbCtD
Toremifene—Loperamide—POMC—kidney cancer	0.000782	0.481	CrCbGaD
Toremifene—Clomifene—CYP1A1—kidney cancer	0.000272	0.168	CrCbGaD
Toremifene—Nervous system disorder—Sunitinib—kidney cancer	0.000179	0.00121	CcSEcCtD
Toremifene—Thrombocytopenia—Sunitinib—kidney cancer	0.000179	0.00121	CcSEcCtD
Toremifene—Skin disorder—Sunitinib—kidney cancer	0.000178	0.0012	CcSEcCtD
Toremifene—Vomiting—Pazopanib—kidney cancer	0.000176	0.00119	CcSEcCtD
Toremifene—Rash—Pazopanib—kidney cancer	0.000175	0.00118	CcSEcCtD
Toremifene—Nausea—Temsirolimus—kidney cancer	0.000175	0.00118	CcSEcCtD
Toremifene—Dermatitis—Pazopanib—kidney cancer	0.000175	0.00118	CcSEcCtD
Toremifene—Anorexia—Sunitinib—kidney cancer	0.000174	0.00117	CcSEcCtD
Toremifene—Back pain—Gemcitabine—kidney cancer	0.000174	0.00117	CcSEcCtD
Toremifene—Headache—Pazopanib—kidney cancer	0.000174	0.00117	CcSEcCtD
Toremifene—Oedema—Dactinomycin—kidney cancer	0.000173	0.00117	CcSEcCtD
Toremifene—Angina pectoris—Capecitabine—kidney cancer	0.000173	0.00116	CcSEcCtD
Toremifene—Vertigo—Vincristine—kidney cancer	0.00017	0.00115	CcSEcCtD
Toremifene—Leukopenia—Vincristine—kidney cancer	0.00017	0.00114	CcSEcCtD
Toremifene—Thrombocytopenia—Dactinomycin—kidney cancer	0.00017	0.00114	CcSEcCtD
Toremifene—Dyspnoea—Sorafenib—kidney cancer	0.00017	0.00114	CcSEcCtD
Toremifene—Dry eye—Doxorubicin—kidney cancer	0.000168	0.00113	CcSEcCtD
Toremifene—Visual impairment—Paclitaxel—kidney cancer	0.000167	0.00112	CcSEcCtD
Toremifene—Insomnia—Sunitinib—kidney cancer	0.000166	0.00111	CcSEcCtD
Toremifene—Decreased appetite—Sorafenib—kidney cancer	0.000165	0.00111	CcSEcCtD
Toremifene—Anorexia—Dactinomycin—kidney cancer	0.000165	0.00111	CcSEcCtD
Toremifene—Nausea—Pazopanib—kidney cancer	0.000165	0.00111	CcSEcCtD
Toremifene—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000164	0.00111	CcSEcCtD
Toremifene—Fatigue—Sorafenib—kidney cancer	0.000164	0.0011	CcSEcCtD
Toremifene—Dyspnoea—Sunitinib—kidney cancer	0.000163	0.0011	CcSEcCtD
Toremifene—Pain—Sorafenib—kidney cancer	0.000163	0.0011	CcSEcCtD
Toremifene—Constipation—Sorafenib—kidney cancer	0.000163	0.0011	CcSEcCtD
Toremifene—Eye disorder—Paclitaxel—kidney cancer	0.000162	0.00109	CcSEcCtD
Toremifene—Weight increased—Capecitabine—kidney cancer	0.000161	0.00109	CcSEcCtD
Toremifene—Leukopenia—Gemcitabine—kidney cancer	0.000161	0.00108	CcSEcCtD
Toremifene—Decreased appetite—Sunitinib—kidney cancer	0.000159	0.00107	CcSEcCtD
Toremifene—Abnormal vision—Doxorubicin—kidney cancer	0.000159	0.00107	CcSEcCtD
Toremifene—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000158	0.00106	CcSEcCtD
Toremifene—Asthenia—Vinblastine—kidney cancer	0.000158	0.00106	CcSEcCtD
Toremifene—Fatigue—Sunitinib—kidney cancer	0.000158	0.00106	CcSEcCtD
Toremifene—Asthenia—Everolimus—kidney cancer	0.000157	0.00106	CcSEcCtD
Toremifene—Angiopathy—Paclitaxel—kidney cancer	0.000157	0.00106	CcSEcCtD
Toremifene—Pain—Sunitinib—kidney cancer	0.000157	0.00105	CcSEcCtD
Toremifene—Constipation—Sunitinib—kidney cancer	0.000157	0.00105	CcSEcCtD
Toremifene—Mediastinal disorder—Paclitaxel—kidney cancer	0.000156	0.00105	CcSEcCtD
Toremifene—Acute coronary syndrome—Capecitabine—kidney cancer	0.000156	0.00105	CcSEcCtD
Toremifene—Chills—Paclitaxel—kidney cancer	0.000155	0.00105	CcSEcCtD
Toremifene—Myocardial infarction—Capecitabine—kidney cancer	0.000155	0.00104	CcSEcCtD
Toremifene—Neuropathy peripheral—Capecitabine—kidney cancer	0.000155	0.00104	CcSEcCtD
Toremifene—Pruritus—Everolimus—kidney cancer	0.000155	0.00104	CcSEcCtD
Toremifene—Oedema—Vincristine—kidney cancer	0.000155	0.00104	CcSEcCtD
Toremifene—Arrhythmia—Paclitaxel—kidney cancer	0.000155	0.00104	CcSEcCtD
Toremifene—Jaundice—Capecitabine—kidney cancer	0.000154	0.00104	CcSEcCtD
Toremifene—Chest pain—Gemcitabine—kidney cancer	0.000153	0.00103	CcSEcCtD
Toremifene—Alopecia—Paclitaxel—kidney cancer	0.000153	0.00103	CcSEcCtD
Toremifene—Thrombophlebitis—Doxorubicin—kidney cancer	0.000153	0.00103	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000152	0.00102	CcSEcCtD
Toremifene—Nervous system disorder—Vincristine—kidney cancer	0.000152	0.00102	CcSEcCtD
Toremifene—Asthenia—Erlotinib—kidney cancer	0.000152	0.00102	CcSEcCtD
Toremifene—Mental disorder—Paclitaxel—kidney cancer	0.000152	0.00102	CcSEcCtD
Toremifene—Thrombocytopenia—Vincristine—kidney cancer	0.000152	0.00102	CcSEcCtD
Toremifene—Malnutrition—Paclitaxel—kidney cancer	0.000151	0.00101	CcSEcCtD
Toremifene—Decreased appetite—Dactinomycin—kidney cancer	0.000151	0.00101	CcSEcCtD
Toremifene—Hyperhidrosis—Vincristine—kidney cancer	0.00015	0.00101	CcSEcCtD
Toremifene—Hepatobiliary disease—Capecitabine—kidney cancer	0.00015	0.00101	CcSEcCtD
Toremifene—Pruritus—Erlotinib—kidney cancer	0.00015	0.00101	CcSEcCtD
Toremifene—Fatigue—Dactinomycin—kidney cancer	0.000149	0.00101	CcSEcCtD
Toremifene—Pain—Dactinomycin—kidney cancer	0.000148	0.000998	CcSEcCtD
Toremifene—Anorexia—Vincristine—kidney cancer	0.000148	0.000994	CcSEcCtD
Toremifene—Oedema—Gemcitabine—kidney cancer	0.000147	0.000989	CcSEcCtD
Toremifene—Back pain—Paclitaxel—kidney cancer	0.000146	0.000981	CcSEcCtD
Toremifene—Dizziness—Vinblastine—kidney cancer	0.000145	0.00098	CcSEcCtD
Toremifene—Dizziness—Everolimus—kidney cancer	0.000145	0.000976	CcSEcCtD
Toremifene—Clomifene—ABCB1—kidney cancer	0.000145	0.089	CrCbGaD
Toremifene—Nervous system disorder—Gemcitabine—kidney cancer	0.000144	0.00097	CcSEcCtD
Toremifene—Thrombocytopenia—Gemcitabine—kidney cancer	0.000144	0.000968	CcSEcCtD
Toremifene—Skin disorder—Gemcitabine—kidney cancer	0.000143	0.000961	CcSEcCtD
Toremifene—Vision blurred—Paclitaxel—kidney cancer	0.000142	0.000956	CcSEcCtD
Toremifene—Hyperhidrosis—Gemcitabine—kidney cancer	0.000142	0.000956	CcSEcCtD
Toremifene—Hot flush—Doxorubicin—kidney cancer	0.000141	0.000953	CcSEcCtD
Toremifene—Diphenhydramine—PTGS1—kidney cancer	0.000141	0.0869	CrCbGaD
Toremifene—Tremor—Paclitaxel—kidney cancer	0.000141	0.00095	CcSEcCtD
Toremifene—Menopausal symptoms—Doxorubicin—kidney cancer	0.00014	0.000944	CcSEcCtD
Toremifene—Insomnia—Vincristine—kidney cancer	0.00014	0.000943	CcSEcCtD
Toremifene—Anorexia—Gemcitabine—kidney cancer	0.00014	0.000943	CcSEcCtD
Toremifene—Vomiting—Vinblastine—kidney cancer	0.00014	0.000942	CcSEcCtD
Toremifene—Dizziness—Erlotinib—kidney cancer	0.00014	0.000941	CcSEcCtD
Toremifene—Vomiting—Everolimus—kidney cancer	0.000139	0.000938	CcSEcCtD
Toremifene—Rash—Everolimus—kidney cancer	0.000138	0.00093	CcSEcCtD
Toremifene—Dermatitis—Everolimus—kidney cancer	0.000138	0.00093	CcSEcCtD
Toremifene—Headache—Vinblastine—kidney cancer	0.000138	0.000928	CcSEcCtD
Toremifene—Headache—Everolimus—kidney cancer	0.000137	0.000924	CcSEcCtD
Toremifene—Visual impairment—Capecitabine—kidney cancer	0.000137	0.000922	CcSEcCtD
Toremifene—Asthenia—Sorafenib—kidney cancer	0.000136	0.000919	CcSEcCtD
Toremifene—Cardiac failure—Doxorubicin—kidney cancer	0.000136	0.000913	CcSEcCtD
Toremifene—Vertigo—Paclitaxel—kidney cancer	0.000135	0.000911	CcSEcCtD
Toremifene—Lethargy—Doxorubicin—kidney cancer	0.000135	0.000909	CcSEcCtD
Toremifene—Leukopenia—Paclitaxel—kidney cancer	0.000135	0.000908	CcSEcCtD
Toremifene—Decreased appetite—Vincristine—kidney cancer	0.000135	0.000906	CcSEcCtD
Toremifene—Pruritus—Sorafenib—kidney cancer	0.000135	0.000906	CcSEcCtD
Toremifene—Vomiting—Erlotinib—kidney cancer	0.000134	0.000905	CcSEcCtD
Toremifene—Gastrointestinal disorder—Vincristine—kidney cancer	0.000134	0.0009	CcSEcCtD
Toremifene—Fatigue—Vincristine—kidney cancer	0.000133	0.000899	CcSEcCtD
Toremifene—Rash—Erlotinib—kidney cancer	0.000133	0.000898	CcSEcCtD
Toremifene—Dermatitis—Erlotinib—kidney cancer	0.000133	0.000897	CcSEcCtD
Toremifene—Insomnia—Gemcitabine—kidney cancer	0.000133	0.000894	CcSEcCtD
Toremifene—Eye disorder—Capecitabine—kidney cancer	0.000133	0.000894	CcSEcCtD
Toremifene—Headache—Erlotinib—kidney cancer	0.000132	0.000892	CcSEcCtD
Toremifene—Pain—Vincristine—kidney cancer	0.000132	0.000891	CcSEcCtD
Toremifene—Constipation—Vincristine—kidney cancer	0.000132	0.000891	CcSEcCtD
Toremifene—Diplopia—Doxorubicin—kidney cancer	0.000132	0.000891	CcSEcCtD
Toremifene—Asthenia—Sunitinib—kidney cancer	0.000131	0.000884	CcSEcCtD
Toremifene—Dyspnoea—Gemcitabine—kidney cancer	0.000131	0.000882	CcSEcCtD
Toremifene—Nausea—Vinblastine—kidney cancer	0.000131	0.00088	CcSEcCtD
Toremifene—Affect lability—Doxorubicin—kidney cancer	0.00013	0.000877	CcSEcCtD
Toremifene—Nausea—Everolimus—kidney cancer	0.00013	0.000876	CcSEcCtD
Toremifene—Pruritus—Sunitinib—kidney cancer	0.000129	0.000872	CcSEcCtD
Toremifene—Angiopathy—Capecitabine—kidney cancer	0.000129	0.000868	CcSEcCtD
Toremifene—Chest pain—Paclitaxel—kidney cancer	0.000128	0.000864	CcSEcCtD
Toremifene—Mediastinal disorder—Capecitabine—kidney cancer	0.000128	0.000862	CcSEcCtD
Toremifene—Decreased appetite—Gemcitabine—kidney cancer	0.000128	0.00086	CcSEcCtD
Toremifene—Chills—Capecitabine—kidney cancer	0.000127	0.000858	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000127	0.000858	CcSEcCtD
Toremifene—Arrhythmia—Capecitabine—kidney cancer	0.000127	0.000854	CcSEcCtD
Toremifene—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000127	0.000854	CcSEcCtD
Toremifene—Fatigue—Gemcitabine—kidney cancer	0.000127	0.000853	CcSEcCtD
Toremifene—Tamoxifen—CYP1A1—kidney cancer	0.000126	0.0774	CrCbGaD
Toremifene—Dizziness—Sorafenib—kidney cancer	0.000126	0.000847	CcSEcCtD
Toremifene—Pain—Gemcitabine—kidney cancer	0.000126	0.000846	CcSEcCtD
Toremifene—Constipation—Gemcitabine—kidney cancer	0.000126	0.000846	CcSEcCtD
Toremifene—Nausea—Erlotinib—kidney cancer	0.000126	0.000846	CcSEcCtD
Toremifene—Alopecia—Capecitabine—kidney cancer	0.000125	0.000845	CcSEcCtD
Toremifene—Mood swings—Doxorubicin—kidney cancer	0.000125	0.000844	CcSEcCtD
Toremifene—Ataxia—Doxorubicin—kidney cancer	0.000124	0.000838	CcSEcCtD
Toremifene—Mental disorder—Capecitabine—kidney cancer	0.000124	0.000838	CcSEcCtD
Toremifene—Asthenia—Dactinomycin—kidney cancer	0.000124	0.000837	CcSEcCtD
Toremifene—Malnutrition—Capecitabine—kidney cancer	0.000124	0.000833	CcSEcCtD
Toremifene—Oedema—Paclitaxel—kidney cancer	0.000123	0.000828	CcSEcCtD
Toremifene—Liver function test abnormal—Doxorubicin—kidney cancer	0.000122	0.000823	CcSEcCtD
Toremifene—Dizziness—Sunitinib—kidney cancer	0.000121	0.000815	CcSEcCtD
Toremifene—Vomiting—Sorafenib—kidney cancer	0.000121	0.000814	CcSEcCtD
Toremifene—Nervous system disorder—Paclitaxel—kidney cancer	0.000121	0.000812	CcSEcCtD
Toremifene—Thrombocytopenia—Paclitaxel—kidney cancer	0.00012	0.000811	CcSEcCtD
Toremifene—Rash—Sorafenib—kidney cancer	0.00012	0.000808	CcSEcCtD
Toremifene—Dermatitis—Sorafenib—kidney cancer	0.00012	0.000807	CcSEcCtD
Toremifene—Back pain—Capecitabine—kidney cancer	0.00012	0.000805	CcSEcCtD
Toremifene—Breast disorder—Doxorubicin—kidney cancer	0.00012	0.000805	CcSEcCtD
Toremifene—Skin disorder—Paclitaxel—kidney cancer	0.000119	0.000804	CcSEcCtD
Toremifene—Headache—Sorafenib—kidney cancer	0.000119	0.000802	CcSEcCtD
Toremifene—Hyperhidrosis—Paclitaxel—kidney cancer	0.000119	0.0008	CcSEcCtD
Toremifene—Anorexia—Paclitaxel—kidney cancer	0.000117	0.000789	CcSEcCtD
Toremifene—Vision blurred—Capecitabine—kidney cancer	0.000117	0.000785	CcSEcCtD
Toremifene—Vomiting—Sunitinib—kidney cancer	0.000116	0.000784	CcSEcCtD
Toremifene—Tremor—Capecitabine—kidney cancer	0.000116	0.00078	CcSEcCtD
Toremifene—Rash—Sunitinib—kidney cancer	0.000115	0.000777	CcSEcCtD
Toremifene—Dermatitis—Sunitinib—kidney cancer	0.000115	0.000776	CcSEcCtD
Toremifene—Headache—Sunitinib—kidney cancer	0.000115	0.000772	CcSEcCtD
Toremifene—Nausea—Sorafenib—kidney cancer	0.000113	0.000761	CcSEcCtD
Toremifene—Angina pectoris—Doxorubicin—kidney cancer	0.000111	0.00075	CcSEcCtD
Toremifene—Insomnia—Paclitaxel—kidney cancer	0.000111	0.000749	CcSEcCtD
Toremifene—Vertigo—Capecitabine—kidney cancer	0.000111	0.000748	CcSEcCtD
Toremifene—Asthenia—Vincristine—kidney cancer	0.000111	0.000748	CcSEcCtD
Toremifene—Leukopenia—Capecitabine—kidney cancer	0.000111	0.000745	CcSEcCtD
Toremifene—Vomiting—Dactinomycin—kidney cancer	0.00011	0.000742	CcSEcCtD
Toremifene—Dyspnoea—Paclitaxel—kidney cancer	0.00011	0.000738	CcSEcCtD
Toremifene—Rash—Dactinomycin—kidney cancer	0.000109	0.000736	CcSEcCtD
Toremifene—Nausea—Sunitinib—kidney cancer	0.000109	0.000732	CcSEcCtD
Toremifene—Decreased appetite—Paclitaxel—kidney cancer	0.000107	0.00072	CcSEcCtD
Toremifene—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000106	0.000715	CcSEcCtD
Toremifene—Fatigue—Paclitaxel—kidney cancer	0.000106	0.000714	CcSEcCtD
Toremifene—Asthenia—Gemcitabine—kidney cancer	0.000105	0.00071	CcSEcCtD
Toremifene—Chest pain—Capecitabine—kidney cancer	0.000105	0.000709	CcSEcCtD
Toremifene—Pain—Paclitaxel—kidney cancer	0.000105	0.000708	CcSEcCtD
Toremifene—Constipation—Paclitaxel—kidney cancer	0.000105	0.000708	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000105	0.000704	CcSEcCtD
Toremifene—Weight increased—Doxorubicin—kidney cancer	0.000104	0.000701	CcSEcCtD
Toremifene—Pruritus—Gemcitabine—kidney cancer	0.000104	0.0007	CcSEcCtD
Toremifene—Nausea—Dactinomycin—kidney cancer	0.000103	0.000693	CcSEcCtD
Toremifene—Dizziness—Vincristine—kidney cancer	0.000102	0.000689	CcSEcCtD
Toremifene—Oedema—Capecitabine—kidney cancer	0.000101	0.000679	CcSEcCtD
Toremifene—Neuropathy peripheral—Doxorubicin—kidney cancer	0.0001	0.000673	CcSEcCtD
Toremifene—Jaundice—Doxorubicin—kidney cancer	9.94e-05	0.000669	CcSEcCtD
Toremifene—Nervous system disorder—Capecitabine—kidney cancer	9.89e-05	0.000666	CcSEcCtD
Toremifene—Thrombocytopenia—Capecitabine—kidney cancer	9.88e-05	0.000665	CcSEcCtD
Toremifene—Vomiting—Vincristine—kidney cancer	9.84e-05	0.000663	CcSEcCtD
Toremifene—Skin disorder—Capecitabine—kidney cancer	9.8e-05	0.00066	CcSEcCtD
Toremifene—Sweating—Doxorubicin—kidney cancer	9.78e-05	0.000658	CcSEcCtD
Toremifene—Rash—Vincristine—kidney cancer	9.76e-05	0.000657	CcSEcCtD
Toremifene—Hyperhidrosis—Capecitabine—kidney cancer	9.75e-05	0.000657	CcSEcCtD
Toremifene—Dermatitis—Vincristine—kidney cancer	9.75e-05	0.000657	CcSEcCtD
Toremifene—Headache—Vincristine—kidney cancer	9.7e-05	0.000653	CcSEcCtD
Toremifene—Hepatobiliary disease—Doxorubicin—kidney cancer	9.64e-05	0.000649	CcSEcCtD
Toremifene—Anorexia—Capecitabine—kidney cancer	9.62e-05	0.000648	CcSEcCtD
Toremifene—Vomiting—Gemcitabine—kidney cancer	9.34e-05	0.000629	CcSEcCtD
Toremifene—Loperamide—ABCB1—kidney cancer	9.32e-05	0.0573	CrCbGaD
Toremifene—Rash—Gemcitabine—kidney cancer	9.26e-05	0.000624	CcSEcCtD
Toremifene—Dermatitis—Gemcitabine—kidney cancer	9.25e-05	0.000623	CcSEcCtD
Toremifene—Headache—Gemcitabine—kidney cancer	9.2e-05	0.00062	CcSEcCtD
Toremifene—Nausea—Vincristine—kidney cancer	9.19e-05	0.000619	CcSEcCtD
Toremifene—Insomnia—Capecitabine—kidney cancer	9.13e-05	0.000615	CcSEcCtD
Toremifene—Dyspnoea—Capecitabine—kidney cancer	9e-05	0.000606	CcSEcCtD
Toremifene—Visual impairment—Doxorubicin—kidney cancer	8.82e-05	0.000594	CcSEcCtD
Toremifene—Asthenia—Paclitaxel—kidney cancer	8.82e-05	0.000594	CcSEcCtD
Toremifene—Decreased appetite—Capecitabine—kidney cancer	8.77e-05	0.000591	CcSEcCtD
Toremifene—Nausea—Gemcitabine—kidney cancer	8.72e-05	0.000587	CcSEcCtD
Toremifene—Gastrointestinal disorder—Capecitabine—kidney cancer	8.71e-05	0.000587	CcSEcCtD
Toremifene—Fatigue—Capecitabine—kidney cancer	8.7e-05	0.000586	CcSEcCtD
Toremifene—Pruritus—Paclitaxel—kidney cancer	8.7e-05	0.000586	CcSEcCtD
Toremifene—Pain—Capecitabine—kidney cancer	8.63e-05	0.000581	CcSEcCtD
Toremifene—Constipation—Capecitabine—kidney cancer	8.63e-05	0.000581	CcSEcCtD
Toremifene—Eye disorder—Doxorubicin—kidney cancer	8.56e-05	0.000576	CcSEcCtD
Toremifene—Angiopathy—Doxorubicin—kidney cancer	8.31e-05	0.000559	CcSEcCtD
Toremifene—Mediastinal disorder—Doxorubicin—kidney cancer	8.25e-05	0.000556	CcSEcCtD
Toremifene—Chills—Doxorubicin—kidney cancer	8.21e-05	0.000553	CcSEcCtD
Toremifene—Arrhythmia—Doxorubicin—kidney cancer	8.18e-05	0.000551	CcSEcCtD
Toremifene—Dizziness—Paclitaxel—kidney cancer	8.13e-05	0.000548	CcSEcCtD
Toremifene—Alopecia—Doxorubicin—kidney cancer	8.09e-05	0.000545	CcSEcCtD
Toremifene—Mental disorder—Doxorubicin—kidney cancer	8.02e-05	0.00054	CcSEcCtD
Toremifene—Malnutrition—Doxorubicin—kidney cancer	7.97e-05	0.000537	CcSEcCtD
Toremifene—Vomiting—Paclitaxel—kidney cancer	7.82e-05	0.000526	CcSEcCtD
Toremifene—Rash—Paclitaxel—kidney cancer	7.75e-05	0.000522	CcSEcCtD
Toremifene—Dermatitis—Paclitaxel—kidney cancer	7.75e-05	0.000522	CcSEcCtD
Toremifene—Back pain—Doxorubicin—kidney cancer	7.71e-05	0.000519	CcSEcCtD
Toremifene—Headache—Paclitaxel—kidney cancer	7.7e-05	0.000519	CcSEcCtD
Toremifene—Vision blurred—Doxorubicin—kidney cancer	7.51e-05	0.000506	CcSEcCtD
Toremifene—Nausea—Paclitaxel—kidney cancer	7.3e-05	0.000492	CcSEcCtD
Toremifene—Asthenia—Capecitabine—kidney cancer	7.24e-05	0.000488	CcSEcCtD
Toremifene—Vertigo—Doxorubicin—kidney cancer	7.16e-05	0.000482	CcSEcCtD
Toremifene—Pruritus—Capecitabine—kidney cancer	7.14e-05	0.000481	CcSEcCtD
Toremifene—Leukopenia—Doxorubicin—kidney cancer	7.13e-05	0.00048	CcSEcCtD
Toremifene—Chest pain—Doxorubicin—kidney cancer	6.78e-05	0.000457	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	6.74e-05	0.000454	CcSEcCtD
Toremifene—Tamoxifen—ABCB1—kidney cancer	6.69e-05	0.0411	CrCbGaD
Toremifene—Dizziness—Capecitabine—kidney cancer	6.67e-05	0.000449	CcSEcCtD
Toremifene—Oedema—Doxorubicin—kidney cancer	6.5e-05	0.000438	CcSEcCtD
Toremifene—Vomiting—Capecitabine—kidney cancer	6.42e-05	0.000432	CcSEcCtD
Toremifene—Nervous system disorder—Doxorubicin—kidney cancer	6.38e-05	0.00043	CcSEcCtD
Toremifene—Thrombocytopenia—Doxorubicin—kidney cancer	6.37e-05	0.000429	CcSEcCtD
Toremifene—Rash—Capecitabine—kidney cancer	6.36e-05	0.000428	CcSEcCtD
Toremifene—Dermatitis—Capecitabine—kidney cancer	6.36e-05	0.000428	CcSEcCtD
Toremifene—Headache—Capecitabine—kidney cancer	6.32e-05	0.000426	CcSEcCtD
Toremifene—Skin disorder—Doxorubicin—kidney cancer	6.32e-05	0.000425	CcSEcCtD
Toremifene—Hyperhidrosis—Doxorubicin—kidney cancer	6.29e-05	0.000423	CcSEcCtD
Toremifene—Anorexia—Doxorubicin—kidney cancer	6.2e-05	0.000417	CcSEcCtD
Toremifene—Nausea—Capecitabine—kidney cancer	5.99e-05	0.000404	CcSEcCtD
Toremifene—Insomnia—Doxorubicin—kidney cancer	5.88e-05	0.000396	CcSEcCtD
Toremifene—Dyspnoea—Doxorubicin—kidney cancer	5.8e-05	0.00039	CcSEcCtD
Toremifene—Decreased appetite—Doxorubicin—kidney cancer	5.65e-05	0.000381	CcSEcCtD
Toremifene—Gastrointestinal disorder—Doxorubicin—kidney cancer	5.62e-05	0.000378	CcSEcCtD
Toremifene—Fatigue—Doxorubicin—kidney cancer	5.61e-05	0.000378	CcSEcCtD
Toremifene—Constipation—Doxorubicin—kidney cancer	5.56e-05	0.000375	CcSEcCtD
Toremifene—Pain—Doxorubicin—kidney cancer	5.56e-05	0.000375	CcSEcCtD
Toremifene—Asthenia—Doxorubicin—kidney cancer	4.67e-05	0.000314	CcSEcCtD
Toremifene—Pruritus—Doxorubicin—kidney cancer	4.6e-05	0.00031	CcSEcCtD
Toremifene—Dizziness—Doxorubicin—kidney cancer	4.3e-05	0.00029	CcSEcCtD
Toremifene—Vomiting—Doxorubicin—kidney cancer	4.14e-05	0.000278	CcSEcCtD
Toremifene—Rash—Doxorubicin—kidney cancer	4.1e-05	0.000276	CcSEcCtD
Toremifene—Dermatitis—Doxorubicin—kidney cancer	4.1e-05	0.000276	CcSEcCtD
Toremifene—Headache—Doxorubicin—kidney cancer	4.07e-05	0.000274	CcSEcCtD
Toremifene—Nausea—Doxorubicin—kidney cancer	3.86e-05	0.00026	CcSEcCtD
Toremifene—CYP1A2—Metapathway biotransformation—GSTP1—kidney cancer	2.94e-05	0.000799	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	2.93e-05	0.000797	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—MAPK1—kidney cancer	2.87e-05	0.000782	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CCBL1—kidney cancer	2.86e-05	0.000778	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—MAPK1—kidney cancer	2.86e-05	0.000777	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ACY1—kidney cancer	2.86e-05	0.000777	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—VEGFA—kidney cancer	2.84e-05	0.000771	CbGpPWpGaD
Toremifene—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	2.81e-05	0.000764	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—GPC3—kidney cancer	2.74e-05	0.000744	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CER1—kidney cancer	2.74e-05	0.000744	CbGpPWpGaD
Toremifene—CYP1A2—Biological oxidations—GSTM1—kidney cancer	2.74e-05	0.000744	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—KRAS—kidney cancer	2.71e-05	0.000738	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—RPL14—kidney cancer	2.71e-05	0.000738	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—KRAS—kidney cancer	2.7e-05	0.000734	CbGpPWpGaD
Toremifene—CYP1A2—Metapathway biotransformation—GSTM1—kidney cancer	2.7e-05	0.000734	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	2.65e-05	0.000719	CbGpPWpGaD
Toremifene—CYP1A2—Biological oxidations—CYP1A1—kidney cancer	2.59e-05	0.000705	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.59e-05	0.000704	CbGpPWpGaD
Toremifene—CYP1A2—Metapathway biotransformation—CYP1A1—kidney cancer	2.56e-05	0.000696	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	2.5e-05	0.000681	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—PIK3CA—kidney cancer	2.48e-05	0.000675	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PPAT—kidney cancer	2.48e-05	0.000675	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GLIPR1—kidney cancer	2.48e-05	0.000675	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.45e-05	0.000666	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	2.43e-05	0.000662	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PDHB—kidney cancer	2.43e-05	0.000661	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.42e-05	0.000659	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—TP53—kidney cancer	2.41e-05	0.000656	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	2.38e-05	0.000648	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	2.34e-05	0.000636	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—SFRP2—kidney cancer	2.33e-05	0.000633	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—FH—kidney cancer	2.31e-05	0.000627	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—APRT—kidney cancer	2.31e-05	0.000627	CbGpPWpGaD
Toremifene—CYP3A4—Biological oxidations—GSTP1—kidney cancer	2.3e-05	0.000625	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CCBL1—kidney cancer	2.29e-05	0.000621	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ACY1—kidney cancer	2.28e-05	0.000621	CbGpPWpGaD
Toremifene—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	2.27e-05	0.000616	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.25e-05	0.000613	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	2.25e-05	0.000612	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—EIF4EBP1—kidney cancer	2.21e-05	0.000601	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—HSPB1—kidney cancer	2.21e-05	0.000601	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GPC3—kidney cancer	2.17e-05	0.00059	CbGpPWpGaD
Toremifene—CYP3A4—Biological oxidations—GSTM1—kidney cancer	2.11e-05	0.000574	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CA2—kidney cancer	2.11e-05	0.000574	CbGpPWpGaD
Toremifene—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	2.08e-05	0.000566	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	2.07e-05	0.000562	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—PSMD7—kidney cancer	2.06e-05	0.000559	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ALAD—kidney cancer	2.06e-05	0.000559	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ST3GAL2—kidney cancer	2.01e-05	0.000546	CbGpPWpGaD
Toremifene—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	2e-05	0.000544	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	2e-05	0.000544	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PPAT—kidney cancer	1.98e-05	0.000539	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GLIPR1—kidney cancer	1.98e-05	0.000539	CbGpPWpGaD
Toremifene—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	1.97e-05	0.000537	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ALDH1A1—kidney cancer	1.96e-05	0.000533	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	1.95e-05	0.000529	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PDHB—kidney cancer	1.94e-05	0.000528	CbGpPWpGaD
Toremifene—CYP1A2—Biological oxidations—POMC—kidney cancer	1.93e-05	0.000526	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PGK1—kidney cancer	1.88e-05	0.000511	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—SLC5A3—kidney cancer	1.88e-05	0.000511	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—AKAP13—kidney cancer	1.88e-05	0.00051	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CASP2—kidney cancer	1.88e-05	0.00051	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—JUNB—kidney cancer	1.85e-05	0.000502	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—LDHB—kidney cancer	1.84e-05	0.000501	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—FH—kidney cancer	1.84e-05	0.000501	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—APRT—kidney cancer	1.84e-05	0.000501	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	1.84e-05	0.0005	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CCBL1—kidney cancer	1.82e-05	0.000496	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	1.82e-05	0.000494	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	1.78e-05	0.000483	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ACY1—kidney cancer	1.76e-05	0.000479	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GPC3—kidney cancer	1.73e-05	0.000471	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—GRB7—kidney cancer	1.72e-05	0.000467	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	1.69e-05	0.00046	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CA2—kidney cancer	1.68e-05	0.000458	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	1.68e-05	0.000458	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.65e-05	0.000449	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ALAD—kidney cancer	1.64e-05	0.000446	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	1.63e-05	0.000444	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	1.61e-05	0.000437	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ST3GAL2—kidney cancer	1.6e-05	0.000436	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	1.6e-05	0.000436	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CA9—kidney cancer	1.6e-05	0.000435	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—ITPR2—kidney cancer	1.6e-05	0.000434	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	1.59e-05	0.000432	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PPAT—kidney cancer	1.58e-05	0.00043	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GLIPR1—kidney cancer	1.58e-05	0.00043	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ALDH1A1—kidney cancer	1.57e-05	0.000426	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.56e-05	0.000425	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	1.55e-05	0.000421	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.55e-05	0.00042	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—CDKN2B—kidney cancer	1.5e-05	0.000409	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PGK1—kidney cancer	1.5e-05	0.000408	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—SLC5A3—kidney cancer	1.5e-05	0.000408	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PDHB—kidney cancer	1.5e-05	0.000407	CbGpPWpGaD
Toremifene—CYP3A4—Biological oxidations—POMC—kidney cancer	1.49e-05	0.000406	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—LDHB—kidney cancer	1.47e-05	0.0004	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—APRT—kidney cancer	1.47e-05	0.0004	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—FH—kidney cancer	1.47e-05	0.0004	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CTNNA1—kidney cancer	1.45e-05	0.000393	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—EIF4EBP1—kidney cancer	1.44e-05	0.000391	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—HSPB1—kidney cancer	1.44e-05	0.000391	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.44e-05	0.000391	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CCBL1—kidney cancer	1.41e-05	0.000383	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	1.4e-05	0.000381	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GPC3—kidney cancer	1.38e-05	0.000376	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CRABP1—kidney cancer	1.36e-05	0.00037	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CA2—kidney cancer	1.35e-05	0.000366	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PSMD7—kidney cancer	1.34e-05	0.000363	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TSC1—kidney cancer	1.34e-05	0.000363	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—ANXA1—kidney cancer	1.34e-05	0.000363	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	1.32e-05	0.00036	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ALAD—kidney cancer	1.31e-05	0.000356	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—FLT1—kidney cancer	1.29e-05	0.000352	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	1.29e-05	0.00035	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ST3GAL2—kidney cancer	1.28e-05	0.000348	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CA9—kidney cancer	1.28e-05	0.000347	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ITPR2—kidney cancer	1.26e-05	0.000344	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	1.26e-05	0.000343	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ALDH1A1—kidney cancer	1.25e-05	0.00034	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.22e-05	0.000332	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PPAT—kidney cancer	1.22e-05	0.000332	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—MYC—kidney cancer	1.21e-05	0.000329	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PAK1—kidney cancer	1.2e-05	0.000326	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—JUNB—kidney cancer	1.2e-05	0.000326	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—SLC5A3—kidney cancer	1.2e-05	0.000326	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PGK1—kidney cancer	1.2e-05	0.000326	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	1.19e-05	0.000324	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—LDHB—kidney cancer	1.18e-05	0.00032	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.17e-05	0.000317	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GSTT1—kidney cancer	1.15e-05	0.000313	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ACHE—kidney cancer	1.15e-05	0.000313	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—FH—kidney cancer	1.14e-05	0.000309	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—APRT—kidney cancer	1.14e-05	0.000309	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	1.09e-05	0.000297	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—SCARB1—kidney cancer	1.09e-05	0.000297	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CRABP1—kidney cancer	1.09e-05	0.000295	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PTGS1—kidney cancer	1.08e-05	0.000294	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GPC3—kidney cancer	1.07e-05	0.00029	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PSMD7—kidney cancer	1.06e-05	0.000288	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	1.06e-05	0.000288	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CA2—kidney cancer	1.04e-05	0.000282	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CA9—kidney cancer	1.02e-05	0.000277	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ALAD—kidney cancer	1.01e-05	0.000275	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ITPR2—kidney cancer	1.01e-05	0.000274	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—BCHE—kidney cancer	1e-05	0.000273	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	9.96e-06	0.000271	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—SLC5A5—kidney cancer	9.92e-06	0.00027	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ST3GAL2—kidney cancer	9.87e-06	0.000268	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IGF2—kidney cancer	9.81e-06	0.000267	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CDKN2B—kidney cancer	9.77e-06	0.000266	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ALDH1A1—kidney cancer	9.65e-06	0.000262	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—SLC2A1—kidney cancer	9.58e-06	0.00026	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IGF1R—kidney cancer	9.49e-06	0.000258	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	9.29e-06	0.000253	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PGK1—kidney cancer	9.25e-06	0.000252	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—SLC5A3—kidney cancer	9.25e-06	0.000252	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ACHE—kidney cancer	9.21e-06	0.00025	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GSTT1—kidney cancer	9.21e-06	0.00025	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—LDHB—kidney cancer	9.07e-06	0.000247	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—SCARB1—kidney cancer	8.71e-06	0.000237	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CRABP1—kidney cancer	8.67e-06	0.000236	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PTGS1—kidney cancer	8.63e-06	0.000235	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PSMD7—kidney cancer	8.46e-06	0.00023	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	8.1e-06	0.00022	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ITPR2—kidney cancer	8.06e-06	0.000219	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—BCHE—kidney cancer	8.02e-06	0.000218	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GSTP1—kidney cancer	7.99e-06	0.000217	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—SLC5A5—kidney cancer	7.92e-06	0.000215	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CA9—kidney cancer	7.87e-06	0.000214	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—HIF1A—kidney cancer	7.81e-06	0.000212	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TSC2—kidney cancer	7.79e-06	0.000212	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—SLC2A1—kidney cancer	7.65e-06	0.000208	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ABCB1—kidney cancer	7.56e-06	0.000206	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—KDR—kidney cancer	7.47e-06	0.000203	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	7.43e-06	0.000202	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ACHE—kidney cancer	7.35e-06	0.0002	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GSTT1—kidney cancer	7.35e-06	0.0002	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GSTM1—kidney cancer	7.34e-06	0.0002	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	7.3e-06	0.000198	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—SCARB1—kidney cancer	6.96e-06	0.000189	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PTGS1—kidney cancer	6.89e-06	0.000187	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—KIT—kidney cancer	6.88e-06	0.000187	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—APC—kidney cancer	6.88e-06	0.000187	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PSMD7—kidney cancer	6.75e-06	0.000184	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CRABP1—kidney cancer	6.69e-06	0.000182	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—POMC—kidney cancer	6.55e-06	0.000178	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—BRAF—kidney cancer	6.47e-06	0.000176	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—BCHE—kidney cancer	6.4e-06	0.000174	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GSTP1—kidney cancer	6.38e-06	0.000173	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—SLC5A5—kidney cancer	6.32e-06	0.000172	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ITPR2—kidney cancer	6.22e-06	0.000169	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—SLC2A1—kidney cancer	6.11e-06	0.000166	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—MAPK3—kidney cancer	5.99e-06	0.000163	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	5.93e-06	0.000161	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GSTM1—kidney cancer	5.86e-06	0.000159	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—MYC—kidney cancer	5.82e-06	0.000158	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.72e-06	0.000155	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ACHE—kidney cancer	5.67e-06	0.000154	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GSTT1—kidney cancer	5.67e-06	0.000154	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CYP1A1—kidney cancer	5.56e-06	0.000151	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—RAF1—kidney cancer	5.4e-06	0.000147	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—RELA—kidney cancer	5.38e-06	0.000146	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—SCARB1—kidney cancer	5.37e-06	0.000146	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—ERBB2—kidney cancer	5.34e-06	0.000145	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PTGS1—kidney cancer	5.31e-06	0.000144	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MTOR—kidney cancer	5.27e-06	0.000143	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PSMD7—kidney cancer	5.21e-06	0.000142	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—POMC—kidney cancer	5.19e-06	0.000141	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.17e-06	0.00014	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GSTP1—kidney cancer	5.09e-06	0.000138	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CDKN1B—kidney cancer	4.95e-06	0.000135	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—BCHE—kidney cancer	4.94e-06	0.000134	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—SLC5A5—kidney cancer	4.88e-06	0.000133	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IL2—kidney cancer	4.84e-06	0.000132	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ABCB1—kidney cancer	4.82e-06	0.000131	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CCND1—kidney cancer	4.72e-06	0.000128	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—SLC2A1—kidney cancer	4.71e-06	0.000128	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—JUN—kidney cancer	4.71e-06	0.000128	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GSTM1—kidney cancer	4.68e-06	0.000127	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CTNNB1—kidney cancer	4.67e-06	0.000127	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PTEN—kidney cancer	4.56e-06	0.000124	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CYP1A1—kidney cancer	4.44e-06	0.000121	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—POMC—kidney cancer	4.14e-06	0.000113	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PTGS2—kidney cancer	4.14e-06	0.000113	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—VEGFA—kidney cancer	4.11e-06	0.000112	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GSTP1—kidney cancer	3.93e-06	0.000107	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MAPK3—kidney cancer	3.89e-06	0.000106	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MYC—kidney cancer	3.79e-06	0.000103	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ABCB1—kidney cancer	3.72e-06	0.000101	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MAPK1—kidney cancer	3.7e-06	0.000101	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.65e-06	9.91e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GSTM1—kidney cancer	3.61e-06	9.82e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PTEN—kidney cancer	3.61e-06	9.81e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—KRAS—kidney cancer	3.5e-06	9.51e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CYP1A1—kidney cancer	3.42e-06	9.31e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—POMC—kidney cancer	3.31e-06	8.99e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PTGS2—kidney cancer	3.31e-06	8.99e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PIK3CA—kidney cancer	3.21e-06	8.74e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TP53—kidney cancer	3.11e-06	8.45e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PTEN—kidney cancer	2.88e-06	7.84e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PTGS2—kidney cancer	2.64e-06	7.17e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—POMC—kidney cancer	2.55e-06	6.94e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PIK3CA—kidney cancer	2.55e-06	6.92e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PTEN—kidney cancer	2.3e-06	6.26e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PTGS2—kidney cancer	2.04e-06	5.54e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PIK3CA—kidney cancer	2.03e-06	5.53e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PTEN—kidney cancer	1.78e-06	4.83e-05	CbGpPWpGaD
Toremifene—CYP1A2—urine—kidney cancer	1.66e-06	0.221	CbGeAlD
Toremifene—CYP1A2—Metabolism—PIK3CA—kidney cancer	1.62e-06	4.41e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.25e-06	3.41e-05	CbGpPWpGaD
Toremifene—CYP3A4—urine—kidney cancer	1.2e-06	0.16	CbGeAlD
Toremifene—ESR1—renal system—kidney cancer	5.26e-07	0.07	CbGeAlD
Toremifene—ESR1—kidney—kidney cancer	5.08e-07	0.0677	CbGeAlD
Toremifene—ESR1—gonad—kidney cancer	4.72e-07	0.0628	CbGeAlD
Toremifene—CYP1A2—renal system—kidney cancer	4.05e-07	0.054	CbGeAlD
Toremifene—CYP1A1—renal system—kidney cancer	4e-07	0.0533	CbGeAlD
Toremifene—CYP1A1—kidney—kidney cancer	3.87e-07	0.0515	CbGeAlD
Toremifene—CYP1A1—cardiac atrium—kidney cancer	3.58e-07	0.0477	CbGeAlD
Toremifene—CYP3A4—renal system—kidney cancer	2.93e-07	0.0391	CbGeAlD
Toremifene—CYP3A4—kidney—kidney cancer	2.84e-07	0.0378	CbGeAlD
Toremifene—ABCB1—nephron tubule—kidney cancer	2.29e-07	0.0304	CbGeAlD
Toremifene—ABCB1—renal system—kidney cancer	2.08e-07	0.0277	CbGeAlD
Toremifene—ABCB1—kidney—kidney cancer	2.01e-07	0.0267	CbGeAlD
Toremifene—ABCB1—cortex of kidney—kidney cancer	1.96e-07	0.026	CbGeAlD
Toremifene—ABCB1—gonad—kidney cancer	1.86e-07	0.0248	CbGeAlD
